It currently takes over 10 years and $1.3B to develop a drug. More than 70% of that investment goes into clinical trials, yet only ~10% of candidates make it from Phase I to approval. Evinova - a new health-tech business within the AstraZeneca Group—is here to change the math. We use advanced algori